Summary
- Current Price
- As of today, ALZN price is $1.50, down -22.28% on
- Current Price All-Time High
- ALZN price is currently -100.00% below its historical high of $45,292.50 set on
- Market Cap
- ALZN current market cap is $6M, down -13.71% year-over-year
- PE Ratio
- ALZN PE ratio is unknown
- Revenue
- ALZN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ALZN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Alzamend Neuro, Inc. |
| Ticker | NASDAQ: ALZN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | alzamend.com |
| Employees | 4 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.50 | ||
| Price, 1D Change | -22.28% | |
| $6M | ||
| - | ||
| - | ||
| 0.31 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$11.32 | ||
| EPS, 1Y Change | +22.98% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:9 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$11.32 | ||
| EPS Estimate | N/A | -$2.52 |
| EPS Est. Change | N/A | +77.75% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.50 | ||
| Price Target | - | $28.00 |
| Price Tgt. Change | - | +1,766.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$14.50 | -$14.70 | -1.40% | |
| -$11.88 | -$11.32 | +4.68% | |
| -$2.52 | N/A | +77.75% | |
| -$2.60 | N/A | +77.04% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -83.33% | ||
| -99.75% | ||
| -13.71% | ||
| -86.55% | ||
| 0.00% | ||
| 0.00% | ||
| +22.98% | ||
| +45.59% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.50 | ||
| $2.36 | ||
| SMA 200 vs Price | +57.57% | |
| $2.02 | ||
| SMA 50 vs Price | +34.45% | |
| 0.31 | ||
| $0.19 | ||
| 33.23 | ||
| 134.42% | ||
| 104.98% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$11.32 | ||
| -$50.70K | ||
| - | ||
| -$4.50M | ||
| - | ||
| -$4.51M | ||
| - | ||
| -$4.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.58 | ||
| 6.58 | ||
| - | ||
| - | ||
| -14.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.61 | ||
| -0.43 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $3.97M | ||
| $3.95M | ||
| $4.60M | ||
| $4.18M | ||
| $634.80K | ||
| $634.80K | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $4.51M | ||
| $4.45M | ||
| $50.70K | ||
| $0.00 | ||
| $50.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.57M | ||
| -$300.00K | ||
| $10.44M | ||
| $300.00K | ||
| -$6.87M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Maxim Group | ||
| Ascendiant Capital |
Analyst sentiment
Institutional ownership
Screeners with ALZN
FAQ
What is the ticker symbol for Alzamend Neuro, Inc.?
The ticker symbol for Alzamend Neuro, Inc. is NASDAQ:ALZN
Does Alzamend Neuro, Inc. pay dividends?
No, Alzamend Neuro, Inc. does not pay dividends
What sector is Alzamend Neuro, Inc. in?
Alzamend Neuro, Inc. is in the Healthcare sector
What industry is Alzamend Neuro, Inc. in?
Alzamend Neuro, Inc. is in the Biotechnology industry
What country is Alzamend Neuro, Inc. based in?
Alzamend Neuro, Inc. is headquartered in United States
When did Alzamend Neuro, Inc. go public?
Alzamend Neuro, Inc. initial public offering (IPO) was on June 15, 2021
Is Alzamend Neuro, Inc. in the S&P 500?
No, Alzamend Neuro, Inc. is not included in the S&P 500 index
Is Alzamend Neuro, Inc. in the NASDAQ 100?
No, Alzamend Neuro, Inc. is not included in the NASDAQ 100 index
Is Alzamend Neuro, Inc. in the Dow Jones?
No, Alzamend Neuro, Inc. is not included in the Dow Jones index
When was Alzamend Neuro, Inc. last earnings report?
Alzamend Neuro, Inc.'s most recent earnings report was on September 11, 2025
When does Alzamend Neuro, Inc. report earnings?
The date for Alzamend Neuro, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ALZN Official Website www.alzamend.com
- ALZN Profile on Yahoo Finance finance.yahoo.com/quote/ALZN
- ALZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alzn